MentionFox
Home › Executive changes › Anaptysbio, Inc
Leadership changes · SEC Form 8-K, Item 5.02

Anaptysbio, Inc executive changes

Every leadership change Anaptysbio, Inc reported to the SEC under Item 5.02: who left, who was appointed, to what role and from when, quoted from each filing.

Filings2
Appointments named3
Latest filing2026-05-11

Anaptysbio, Inc filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-05-11. Between them they name 2 people. Each change below is quoted from the filing and linked to it.

Every change, newest first

Filed 2026-05-11 · 8-K

Appointed: Christopher M. Murphy, Chief Financial Officer, effective 2026-05-11

On May 11, 2026, AnaptysBio, Inc. (the "Company") announced that its Board of Directors (the "Board") appointed Christopher M. Murphy as Chief Financial Officer, effective as of May 11, 2026.

Appointed: Christopher M. Murphy

Mr. Murphy will serve as an independent contractor.

Appointed: Owen Hughes, Director, effective 2026-05-11

On May 8, 2026, the Board appointed Owen Hughes as a Class I director, effective May 11, 2026.
Filed 2026-04-20 · 8-K

Reported

Board Departures In connection with the Spin-Off, each of Dennis Fenton, Rita Jain and Magda Marquet resigned from the board of directors of the Company, effective as of April 20, 2026, and J. Anthony Ware resigned from the board of directors of the Company, effective as of April 23, 2026.
Hiring for a seat like this?

Find people with the same kind of experience as the Chief Financial Officer at Anaptysbio, Inc, with the record behind each one.

Find candidates like Chief Financial Officer at Anaptysbio, Inc
Selling to Anaptysbio, Inc?

New leaders review vendors and budgets in their first months. Get an alert the next time Anaptysbio, Inc is in the news or changes leadership.

Get an alert when Anaptysbio, Inc changes leadership

Tools for this story

Each opens in a new tab, filled in for Anaptysbio, Inc. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/anaptysbio
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2
Anaptysbio, Inc (ANAB) executive changes: Christopher M. Murphy appointed, Chief Financial Officer. MentionFox, 2026-09-27. https://mentionfox.com/executive-changes/anaptysbio